Diabetic ketoacidosis (DKA) While considered lower-risk than with SGLT2 inhibitors, DKA can still occur in people with type 1 diabetes taking tirzepatide, particularly if the insulin dose is reduced too aggressively or if the person becomes unwell (e.g
Panels show study design (a), higher plasma TMAO (b), worsened IPGTT (c), reduced insulin/C-peptide responses and GSIS under clamp (dk), pancreatic histology (l), altered islet composition by immunostaining (mo), and increased plasma glucagon (p), supporting a mechanistic link between TMAO and -cell dysfunction
How to maximize weight loss on tirzepatide Everyones weight loss journey is as individual as they are, even on Zepbound
Chronic sleep deprivation can have serious consequences for physical and psychological wellbeing, and persistent insomnia may necessitate referral for cognitive behavioural therapy for insomnia (CBT-I), which is recommended by NICE as the first-line treatment for persistent sleep problems
17, n o 11, 10051010 (DOI 10.1016/j.amjhyper.2004.06.019, lire en ligne, consult le L van Bloemendaal, J S ten Kulve, S E la Fleur et R G Ijzerman, Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS , Journal of Endocrinology , vol